A team of Chinese scientists has uncovered a hidden 3D structure in rice DNA that allows the crop to grow more grain while ...
The ability of immune cells—particularly CD8+ T cells—to launch a rapid burst of proliferation inside tumors is key to the ...
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...
These long-term findings in a large patient cohort show the sustained clinical efficacy and safety of autologous CD34+ hematopoietic stem-cell lentiviral gene therapy for ADA-SCID, indicating that it ...
A Washington man appeared to be destined to develop Alzheimer’s disease — but against all genetic odds, he has eluded the common dementia for decades. Researchers at the Washington University School ...
AUSTIN, Texas, Oct. 14, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...
Regeneron is clearing a regulatory path for its investigational gene therapy DB-OTO after an early phase study demonstrated hearing improvements in children with a genetic form of deafness. The data, ...
Genetic deficiency of otoferlin, a protein critical to synaptic transmission by the sensory hair cells of the ear, causes congenital deafness. Medicines to treat the condition are lacking; children ...
Each year, a small number of babies are born mostly, if not fully, deaf because one of their genes isn’t working. The gene normally makes a protein that the hairs in our inner ears need to relay sound ...
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback